News and Announcements
OncoSil Medical Appoints New CFO
- Published October 22, 2015 1:07PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
22nd October 2015, ASX Announcement
OncoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to announce the appointment of Mr Tom Milicevic as Chief Financial Officer and Company Secretary, effective from 22 October 2015.
Mr Milicevic is a vastly experienced commercial, financial and management accountant with more than 20 years’ experience in a career which includes a number of major Australian and international public companies.
He has specific financial expertise in medical device and biotech companies and his appointment represents a pivotal hire for the Company as it transitions from a development focus to the commercialisation of its OncoSilTM localised radiation treatment for cancer.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
